A stratified model for psychosis prediction in clinical practice

Schizophrenia Bulletin

Volumn 40, Issue 6, 2014, Pages 1533-1542

  Michel, Chantal ^a   Ruhrmann, Stephan ^b   Schimmelmann, Benno G ^a   Klosterkötter, Joachim ^b   Schultze Lutter, Frauke ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

at risk criteria; neurocognition; prediction; processing speed; psychosis; risk estimation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL PRACTICE; COGNITIVE DEFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PREDICTION; PSYCHOSIS; RECALL; RISK ASSESSMENT; SURVIVAL RATE; COGNITION DISORDERS; COMPLICATION; FOLLOW UP; NEUROPSYCHOLOGICAL TEST; PROGNOSIS; PSYCHOTIC DISORDERS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; COGNITION DISORDERS; FOLLOW-UP STUDIES; HUMANS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PSYCHOTIC DISORDERS; RISK ASSESSMENT; YOUNG ADULT;

EID: 84911195872     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbu025     Document Type: Article

References (66)

1. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med. 2001;31:189-195.
2. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160:13-23.
3. Schaefer J, Giangrande E, Weinberger DR, Dickinson D. The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res. 2013;150:42-50.
4. Lewandowski KE, Cohen BM, Ongur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med. 2011;41:225-241.
5. Häfner H, Nowotny B, Löffler W, an der Heiden W, Maurer K. When and how does schizophrenia produce social deficits? Eur Arch Psychiatry Clin Neurosci. 1995;246:17-28.
6. Cascio MT, Cella M, Preti A, Meneghelli A, Cocchi A. Gender and duration of untreated psychosis: a systematic review and meta-analysis. Early Interv Psychiatry. 2012;6:115-127.
7. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62:975-983.
8. Schimmelmann BG, Huber CG, Lambert M, Cotton S, McGorry PD, Conus P. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J Psychiatr Res. 2008;42:982-990.
9. Keshavan MS, Haas G, Miewald J, et al. Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull. 2003;29:757-769.
10. Cuesta MJ, García de Jalón E, Campos MS, Ibáñez B, Sánchez-Torres AM, Peralta V. Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis. Schizophr Res. 2012;141:222-227.
11. McGorry PD. "A stitch in time". The scope for preventive strategies in early psychosis. Eur Arch Psychiatry Clin Neurosci. 1998;248:22-31.
12. Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high-risk state: A comprehensive state-of-the-art review. JAMA Psychiatry. 2013;70:107-120.
13. Fusar-Poli P, Deste G, Smieskova R, et al. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry. 2012;69:562-571.
14. Giuliano AJ, Li H, Mesholam-Gately RI, Sorenson SM, Woodberry KA, Seidman LJ. Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr Pharm Des. 2012;18:399-415.
15. Pukrop R, Ruhrmann S. Neurocognitive indicators of highrisk states for psychosis. In: Fusar Poli P, Borgwardt S, McGuire P, eds. Vulnerability to Psychosis - From Neuroscience to Psychopathology. Hove, NY: Psychology Press; 2012:73-94.
16. De Herdt A, Wampers M, Vancampfort D, et al. Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a metaanalysis. Schizophr Res. 2013;149:48-55.
17. Frommann I, Pukrop R, Brinkmeyer J, et al. Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early-and additional memory dysfunction in the late-prodromal state. Schizophr Bull. 2011;37:861-873.
18. Pukrop R, Ruhrmann S, Schultze-Lutter F, Bechdolf A, Brockhaus-Dumke A, Klosterkötter J. Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis. Schizophr Res. 2007;92:116-125.
19. Lin A, Wood SJ, Nelson B, et al. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis. Schizophr Res. 2011;132:1-7.
20. Bowie CR, Leung WW, Reichenberg A, et al. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry. 2008;63:505-511.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Publishing; 2013.
22. Barch DM, Bustillo J, Gaebel W, et al. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophr Res. 2013;150:15-20.
23. Lin A, Yung AR, Nelson B, et al. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis. Psychol Med. 2013;43:2349-2360.
24. Keefe RS, Perkins DO, Gu H, Zipursky RB, Christensen BK, Lieberman JA. A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr Res. 2006;88:26-35.
25. Riecher-Rössler A, Pflueger MO, Aston J, et al. Efficacy of using cognitive status in predicting psychosis: a 7-year followup. Biol Psychiatry. 2009;66:1023-1030.
26. Ruhrmann S, Schultze-Lutter F, Salokangas RK, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry. 2010;67:241-251.
27. Nieman DH, Ruhrmann S, Dragt S, et al. Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables. Schizophr Bull. 2013. doi:10.1093/schbul/sbt145.
28. McGlashan T, Walsh B, Woods S. The Psychosis-Risk Syndrome. Handbook for Diagnosis and Follow-Up. New York, NY: Oxford University Press; 2010.
29. Schultze-Lutter F, Addington J, Ruhrmann S, Klosterkötter J. Schizophrenia Proneness Instrument, Adult version (SPI-A). Rome, Italy: Giovanni Fioriti Editore s.r.l.; 2007.
30. Schultze-Lutter F, Ruhrmann S, Klosterkötter J. Early detection of psychosis - establishing a service for persons at risk. Eur Psychiatry. 2009;24:1-10.
31. Wittchen HU, Zaudig M, Fydrich T. SKID Strukturiertes Klinisches Interview für DSM-IV. Dt. Bearbeitung (Structured Clinical Interview for DSM-IV. German version). Göttingen, Germany: Hogrefe; 1997.
32. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest: MWT-B [Multiple Choice Vocabulary Test]. Nürnberg, Germany: perimed-spitta; 1995.
33. Schultze-Lutter F, Ruhrmann S, Picker H, et al. Subjective and objective cognitive function in the prodrome. Br J Psychiatry. 2007;191:43-51.
34. Cornblatt BA. Continous Performance Test - Identical Pairs Version computer software. New York, NY: Author; 1996.
35. Bergida H, Lenzenweger MF. Schizotypy and sustained attention: confirming evidence from an adult community sample. J Abnorm Psychol. 2006;115:545-551.
36. Lezak MD. Neuropsychological Assessment. 3rd ed. New York, NY: Oxford University Press; 1995.
37. Helmstaedter C, Lendt M, Lux S. Verbaler Lern- und Merkfähigkeitstest. Göttingen, Germany: Beltz Test GmbH; 2001.
38. Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique (Psychological examination of cases wtih traumatic encephalopathy). Arch Psychol. 1941;28:286-340.
39. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests. 3rd ed. New York, NY: Oxford University Press; 2006.
40. Pukrop R, Matuschek E, Ruhrmann S, et al. Dimensions of working memory dysfunction in schizophrenia. Schizophr Res. 2003;62:259-268.
41. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtis G. Wisconsin Card Sorting Test Manual. Odessa, FL: Psychological Assessment Resources; 1993.
42. Aschenbrenner S, Tucha O, Lange KW. Regensburger Wortflüssigkeitstest (RWT). Göttingen, Germany: Hogrefe; 2000.
43. Kaplan E, Fein D, Morris R, Delis D. WAIS-R NI Manual. WAIS-R as a Neuropsychological Instrument. San Antonio, TX: Psychological Corporation; 1991.
44. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Tucson, AZ: Neuropsychology Press; 1985.
45. Hosmer WD, Lemeshow S. Applied Survival Analysis: Regression Modelling of Time to Event Data. Hoboken, NJ: Wiley & Sons; 1999.
46. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710-718.
47. Tropsha A, Gramatica P, Gombar VK. The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci. 2003;22:69-77.
48. Loughin TM. On the bootstrap and monotone likelihood in the cox proportional hazards regression model. Lifetime Data Anal. 1998;4:393-403.
49. Carrión RE, Goldberg TE, McLaughlin D, Auther AM, Correll CU, Cornblatt BA. Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. Am J Psychiatry. 2011;168:806-813.
50. Kelleher I, Murtagh A, Clarke MC, Murphy J, Rawdon C, Cannon M. Neurocognitive performance of a communitybased sample of young people at putative ultra high risk for psychosis: support for the processing speed hypothesis. Cogn Neuropsychiatry. 2013;18:9-25.
51. Niarchou M, Zammit S, Walters J, Lewis G, Owen MJ, van den Bree MB. Defective processing speed and nonclinical psychotic experiences in children: longitudinal analyses in a large birth cohort. Am J Psychiatry. 2013;170:550-557.
52. Cannon M, Moffitt TE, Caspi A, Murray RM, Harrington H, Poulton R. Neuropsychological performance at the age of 13 years and adult schizophreniform disorder: prospective birth cohort study. Br J Psychiatry. 2006;189:463-464.
53. Niendam TA, Bearden CE, Rosso IM, et al. A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. Am J Psychiatry. 2003;160:2060-2062.
54. Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 2007;64:532-542.
55. Rodríguez-Sánchez JM, Crespo-Facorro B, González-Blanch C, Pérez-Iglesias R, Vázquez-Barquero JL. Cognitive dysfunction in first-episode psychosis: the processing speed hypothesis. Br J Psychiatry. 2007;191:107-110.
56. Carrión RE, McLaughlin D, Goldberg TE, et al. Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry. 2013;70:1133-1142.
57. Turken A, Whitfield-Gabrieli S, Bammer R, Baldo JV, Dronkers NF, Gabrieli JD. Cognitive processing speed and the structure of white matter pathways: convergent evidence from normal variation and lesion studies. Neuroimage. 2008;42:1032-1044.
58. Samartzis L, Dima D, Fusar-Poli P, Kyriakopoulos M. White matter alterations in early stages of schizophrenia: a systematic review of diffusion tensor imaging studies. J Neuroimaging. 2013. doi:10.1111/j.1552-6569.2012.00779.x.
59. Friston KJ, Frith CD. Schizophrenia: a disconnection syndrome? Clin Neurosci. 1995;3:89-97.
60. Carletti F, Woolley JB, Bhattacharyya S, et al. Alterations in white matter evident before the onset of psychosis. Schizophr Bull. 2012;38:1170-1179.
61. Koutsouleris N, Gaser C, Patschurek-Kliche K, et al. Multivariate patterns of brain-cognition associations relating to vulnerability and clinical outcome in the at-risk mental states for psychosis. Hum Brain Mapp. 2012;33:2104-2124.
62. Fusar-Poli P, Bechdolf A, Taylor MJ, et al. At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr Bull. 2013;39:923-932.
63. Segev A, Lev-Ran S. Neurocognitive functioning and cannabis use in schizophrenia. Curr Pharm Des. 2012;18:4999-5007.
64. Addington J, Cadenhead KS, Cannon TD, et al. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007;33:665-672.
65. Addington J, Cadenhead KS, Cornblatt BA, et al. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res. 2012;142:77-82.
66. Andersson S, Lövdahl H, Malt UF. Neuropsychological function in unmedicated recurrent brief depression. J Affect Disord. 2010;125:155-164.